Patents by Inventor Daniel A. Boon
Daniel A. Boon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11969500Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: GrantFiled: November 10, 2021Date of Patent: April 30, 2024Assignee: Foundry Therapeutics, Inc.Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet
-
Publication number: 20230136789Abstract: The present technology relates to polymer implants. In some embodiments, the polymer implant may have a volume having minimum cross-sectional dimension of 400 ?m. The polymer implant may be configured to be implanted within a mammalian body for at least 3 days without undergoing core acidification.Type: ApplicationFiled: March 5, 2021Publication date: May 4, 2023Inventors: Patrick H. Ruane, Jackie Joe Hancock, Cynthia R. Lee, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang
-
Publication number: 20230045729Abstract: An implantable light delivery device comprises: a core portion cladded in a cladding, the core portion comprising upconversion nano-particles (UCNPs) encapsulated in an encapsulation material. The implantable light delivery device may be used in treatments such as photodynamic therapy to provide an emission of light at a wavelength configured by the selection of UCNPs. The encapsulation material may comprise hydrogel and the cladding may comprise fluorinated ethylene propylene.Type: ApplicationFiled: March 24, 2021Publication date: February 9, 2023Inventors: Daniel Boon Loong TEH, Akshaya BANSAL, Yong ZHANG, Brian Keith KENNEDY, Chou CHAI, Kah Leong LIM
-
Publication number: 20220183963Abstract: The present technology relates to implantable depots for the local, sustained, controlled release of a therapeutic agent to treat cancer. An implantable depot may comprise a biodegradable polymer mixed with a locally-acting therapeutic agent configured to treat cancer. The depot may be configured to be implanted within a patient proximate cancerous tissue and, while implanted, provide sustained exposure of the therapeutic agent at the treatment site for a period of time that is no less than 5 days.Type: ApplicationFiled: April 11, 2020Publication date: June 16, 2022Inventors: Steven Kim, Karun D. Naga, Hanson S. Gifford, III, James Su, Nassireddin Mokarram-Dorri, Mark Deem, Stephen W. Boyd, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang, Edward D. Gifford
-
Publication number: 20220183964Abstract: The present technology relates to depots for the treatment of select symptoms via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising the therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for an extended period of time.Type: ApplicationFiled: April 11, 2020Publication date: June 16, 2022Inventors: Karun D. Naga, Hanson S. Gifford, III, Mark Deem, Stephen W. Boyd, Nassireddin Mokarram-Dorri, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang
-
Publication number: 20220117885Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: ApplicationFiled: November 10, 2021Publication date: April 21, 2022Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet
-
Patent number: 11224570Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: GrantFiled: February 15, 2021Date of Patent: January 18, 2022Assignee: Foundry Therapeutics, Inc.Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet
-
Patent number: 11202754Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: GrantFiled: April 3, 2020Date of Patent: December 21, 2021Assignee: Foundry Therapeutics, Inc.Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet
-
Publication number: 20210353532Abstract: The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days. The assembly further includes a fixation portion coupled to the depot and configured to facilitate attachment of the depot assembly to tissue at or adjacent to the treatment site.Type: ApplicationFiled: August 27, 2019Publication date: November 18, 2021Inventors: Karun D. Naga, Hanson S. Gifford, III, Jackie Joe Hancock, Stephen W. Boyd, John Morriss, Patrick H. Ruane, Michael Feldstein, Darren Doud, Mark Deem, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang
-
Publication number: 20210308338Abstract: The present technology relates to polymer implants. In some embodiments, the polymer implant may have a volume having minimum cross-sectional dimension of 400 ?m. The polymer implant may be configured to be implanted within a mammalian body for at least 3 days without undergoing core acidification.Type: ApplicationFiled: August 27, 2019Publication date: October 7, 2021Inventors: Patrick H. Ruane, Jackie Joe Hancock, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang
-
Publication number: 20210186868Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: ApplicationFiled: February 15, 2021Publication date: June 24, 2021Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet
-
Publication number: 20210069101Abstract: The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising a therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: ApplicationFiled: April 11, 2019Publication date: March 11, 2021Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet, Wei Li Lee, Nassireddin Mokarram-Dorri
-
Publication number: 20200368398Abstract: The devices, systems, and methods disclosed herein may be directed to a delivery system including a therapeutic member configured for endoluminal placement via the delivery system into the esophagus of the patient, wherein the therapeutic member comprises a treatment portion comprising a film for controlled release of a chemotherapeutic agent. The film may comprise a control region, a therapeutic region, and a substantially impermeable base region. The film is configured to release the chemotherapeutic agent in a direction away from the substantially impermeable base region. The delivery system is configured to enable a treatment provider to position the treatment portion of the therapeutic member proximate to a treatment site associated with the esophagus of the patient, and the therapeutic member is configured to administer a therapeutically effective dose to the treatment site for a sustained period following endoluminal placement of the therapeutic member.Type: ApplicationFiled: January 8, 2019Publication date: November 26, 2020Inventors: Karun D. Naga, Stephen W. Boyd, Hanson S. Gifford, III, Mark Deem, John Morriss, Martin Mayse, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet, Koon Kiat Teu, Wei Li Lee
-
Publication number: 20200246255Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.Type: ApplicationFiled: April 3, 2020Publication date: August 6, 2020Inventors: Karun D. Naga, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koot Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet, Hanson S. Gifford, III
-
Publication number: 20130275547Abstract: Providing tailored supplemental content to a user in a Network Address Translation (NAT) environment is described. Network traffic from a user to a supplemental content provider is monitored within a first network and a supplemental content identifier (ID) is identified in the monitored traffic and linked to a profile of the device or user of the device. A supplemental content provider on a second network receives a request for supplemental content that includes the supplemental content ID and uses the received supplemental content ID to retrieve the profile linked to the supplemental content ID. Supplemental content may then be generated or retrieved based on the retrieved profile and returned to the user device.Type: ApplicationFiled: April 16, 2012Publication date: October 17, 2013Applicant: KINDSIGHT INC.Inventors: Daniel Boon Ling Chew, Roderick William Macdonald, Russell Offen, Richard Kenneth Algernon Chin
-
Patent number: 4181037Abstract: Rotatable article supporting plates with cabinet doors attached mounted on a rotatable central supporting shaft, the shaft being suspended, at least partially, from a mechanism for adjusting the vertical alignment of the doors relative to the cabinet door frame. The mechanism may be biased to maintain the doors in a preferred rotational position, e.g. a closed door position relative to the door frame. The preferred rotational position of the mechanism may also be adjusted to rotationally align the doors in their closed door position in the door frame. The mechanism includes a cam gear disposed in a housing which rotates on a sawtooth track in response to the adjustment of a threaded member to raise or lower the shaft and doors.Type: GrantFiled: August 24, 1977Date of Patent: January 1, 1980Assignee: Jones Plastic & Engineering CorporationInventors: Daniel A. Boon, R. Larry Jones, Naaman Shelton, Jr.